A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II Non-Small-Cell Lung Cancer from the Randomized KEYNOTE-671 Study.

Tsuboi M, Wakelee H, Garassino MC, Gao S, Luft A, Chen KN, Spicer JD, Zhu Y, Saji H, Okada M, Vanakesa T, Chen H, Zhao G, Ikeda N, Jones DR, Weksler B, Huang CS, Jensen E, Keller SM, Samkari A, Liberman M

Open source

DOI: 10.1093/ejcts/ezag028
Published: 2026 Mar 10
Container: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ejcts/ezag028,
  title = {A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II Non-Small-Cell Lung Cancer from the Randomized KEYNOTE-671 Study.},
  author = {Tsuboi M and Wakelee H and Garassino MC and Gao S and Luft A and Chen KN and Spicer JD and Zhu Y and Saji H and Okada M and Vanakesa T and Chen H and Zhao G and Ikeda N and Jones DR and Weksler B and Huang CS and Jensen E and Keller SM and Samkari A and Liberman M},
  year = {2026},
  journal = {European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery},
  doi = {10.1093/ejcts/ezag028},
  url = {https://doi.org/10.1093/ejcts/ezag028}
}

RIS

TY  - JOUR
TI  - A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II Non-Small-Cell Lung Cancer from the Randomized KEYNOTE-671 Study.
AU  - Tsuboi M
AU  - Wakelee H
AU  - Garassino MC
AU  - Gao S
AU  - Luft A
AU  - Chen KN
AU  - Spicer JD
AU  - Zhu Y
AU  - Saji H
AU  - Okada M
AU  - Vanakesa T
AU  - Chen H
AU  - Zhao G
AU  - Ikeda N
AU  - Jones DR
AU  - Weksler B
AU  - Huang CS
AU  - Jensen E
AU  - Keller SM
AU  - Samkari A
AU  - Liberman M
PY  - 2026
JO  - European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
DO  - 10.1093/ejcts/ezag028
UR  - https://doi.org/10.1093/ejcts/ezag028
ER  -

APA

M, T., H, W., MC, G., S, G., A, L., KN, C., JD, S., Y, Z., H, S., M, O., T, V., H, C., G, Z., N, I., DR, J., B, W., CS, H., E, J., SM, K., A, S., & M, L. (2026). A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II Non-Small-Cell Lung Cancer from the Randomized KEYNOTE-671 Study.. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. https://doi.org/10.1093/ejcts/ezag028

Source records

pubmed · retrieved 2026-09-26T23:32:10.470Z